Saturday, March 15, 2025 | 12:14 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Gene editing: CRISPR raises many questions about risks and ethics

The idea of eliminating and inserting genes throws up immense possibilities, but it also raises many questions about risks and ethics

Genes
Premium

Devangshu Datta New Delhi
Last October, bioscientist and former NASA researcher, Josiah Zayner tried a path-breaking experiment with himself as the subject. 

Zayner switched on his video camera, invited a few scientists to act as witnesses and edited his own genes. He live-blogged this with a running commentary.

Zayner used a new technology, called CRISPR, to remove the myostatin gene from the cells on his forearm. Myostatin inhibits the growth of muscle. If the experiment works, Zayner should eventually end up having bigger muscles on one forearm
.
But more than the success or failure of this experiment, Zayner was simply demonstrating that genetic hacking (bio-hacking

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in